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Diabetic foot infection is the most common etiology of non-
traumatic amputation of the lower extremities, and early
diagnosis is of great importance in its management. The aim
of this prospective study was to evaluate the strength of 99mTc-
IgG scintigraphy in diagnosis of osteomyelitis of the diabetic
foot and to compare 99mTc-IgG scintigraphy with 99mTc-meth-
ylene diphosphonate (MDP) scintigraphy.Methods: A prospec-
tive university hospital–based study was performed over 24 mo.
Eighteen patients with type II diabetes and foot ulcers (15 men
and 3 women; age range, 45–80 y) were referred for imaging
because of clinically suspected osteomyelitis. Early (5-h) and
late (24-h) 99mTc-IgG scanning and 3-phase skeletal scintigra-
phy were completed for all patients at a 3- to 4-d interval.
Regions of interest over the involved bony sites and the con-
tralateral normal sites were drawn, and the abnormal-to-normal
ratios were acquired for both 99mTc-IgG and 99mTc-MDP stud-
ies. Results: From a total of 23 lesions, we observed 10 sites of
osteomyelitis, 10 sites of cellulitis, and 3 sites of aseptic inflam-
mation confirmed by MRI, clinical presentation, histopathologic
examination, and follow-up evaluation as a gold standard. Both
99mTc-IgG and 99mTc-MDP scanning showed excellent sensitiv-
ity for diagnosis of osteomyelitis, but the specificity was signifi-
cantly lower (69.2% and 53.8%, respectively). Sensitivity,
specificity, and accuracy in the diagnosis of osteomyelitis were,
respectively, 100%, 53.8%, 73.9% for 99mTc-MDP scanning;
100%, 69.2%, 82.6% for 5-h 99mTc-IgG scanning; and 60%,
76.9%, 69.5% for 24-h 99mTc-IgG scanning. There was no sig-
nificant difference between the semiquantitative indices of 5-h
and 24-h 99mTc-IgG scanning for inflammation, cellulitis, and
osteomyelitis. Conclusion: Although both 99mTc-IgG and
99mTc-MDP scintigraphy have high sensitivity for the diagnosis
of osteomyelitis, the specificity of these studies is poor. For
99mTc-IgG scintigraphy, 5-h images appear to be adequate,
and there is little benefit to performing additional imaging at
24 h.
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Peripheral neuropathy and metabolic and vascular dis-
orders are important contributing factors leading to infec-
tion of obscured wounds in diabetic patients (1,2). When
there is evidence of osteomyelitis, invasive procedures are
needed to avoid amputation (3). Radiographic evaluation is
not sensitive for the development of osteomyelitis, whereas
labeled leukocyte imaging followed by bone marrow scin-
tigraphy, although both sensitive and specific, is labor-in-
tensive and limited by the risks associated with handling
blood products (4). 111In-IgG and 99mTc-methylene di-
phosphonate (MDP) scintigraphy can be helpful for the
diagnosis of inflammation and infection (5–11).
The aim of this prospective study was to assess the role
of 99mTc-IgG scintigraphy in the diagnosis of osteomyelitis
in the diabetic foot and to compare 99mTc-IgG scintigraphy
with 99mTc-MDP scintigraphy. In addition to qualitatively
assessing the 99mTc-MDP and 99mTc-IgG studies, we have
attempted to evaluate the clinical usefulness of quantitative
uptake on 99mTc-MDP and 99mTc-IgG scanning in detecting
osteomyelitis in peripheral bony lesions.
MATERIALS AND METHODS
Participants
This study was conducted on 18 patients with type II
diabetes who were referred to our nuclear medicine de-
partment with a clinical suspicion of osteomyelitis. The pa-
tients were recruited from a university hospital in Tehran
from 2006 to 2008. They underwent 99mTc-IgG scanning
first, followed by 3-phase 99mTc-MDP skeletal scanning at
a 3- to 4-d interval.
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The study complied with the declaration of Helsinki and
was approved by the institutional ethics committee of
Shaheed Beheshti University of Medical Science, and all
patients gave written informed consent.
Imaging Protocols
99mTc-IgG Scintigraphy. In both studies, the amount of
intravenously injected 99mTc was about 740 MBq (20 mCi),
and images were acquired by a double-head SPECT scin-
tillation camera (Genesys; ADAC) with a low-energy all-
purpose collimator using a matrix of 128 · 128 on a 20%
window at a 140-keV peak. The intensity settings of the
scintillation camera were carefully monitored so that im-
ages of comparable counts and intensities were available
for interpretation. Three nuclear medicine consultants un-
aware of other data evaluated the scintigraphic studies and
reached the final impression by consensus.
For 99mTc-IgG scintigraphy, a human nonspecific poly-
clonal immunoglobulin for intravenous administration was
used. An IgG solution with a concentration of about 10 mg/
mL in 0.01 M phosphate-buffered saline, pH 7.4, was pre-
pared. 99mTc-IgG was prepared by adding 740 MBq (20
mCi) of 99mTc to an IgG kit provided by the Nuclear
Energy Institute of Iran and incubating for 20 min at room
temperature. 99mTc-IgG was administered intravenously,
and early (5-h) and delayed (24-h) imaging was performed
minimally in 2 views, for at least 400,000 counts and 50,000
counts, respectively. Images of the contralateral normal ana-
tomic region were also obtained.
99mTc-MDP Scintigraphy. Skeletal scans were obtained
using 740 MBq of 99mTc-MDP. The first phase of the skeletal
scan consisted of the radionuclide angiogram, comprising
sequential images at 2–3 s per frame over the involved region
of suspected osteomyelitis and the opposite presumed normal
anatomic region. The flow phase was performed for 60 s,
followed by a blood-pool image at 180 s after intravenous
injection of the radiopharmaceutical. Delayed images were
obtained 3 h after 99mTc-MDP injection using the same pro-
jections for at least 500,000 counts.
Visual Interpretation
The determination of osteomyelitis was based on signifi-
cant uptake of radiopharmaceutical in all 3 phases of 99mTc-
MDP scanning or an intense accumulation on 99mTc-IgG
scanning (Fig. 1). Accumulation of radionuclide in only
the first 2 phases of skeletal scanning or a mild to moderate
uptake on 99mTc-IgG scanning was characterized as cellulitis
(Fig. 2). If there was remarkable radionuclide uptake on
99mTc-MDP scanning without significant uptake on 99mTc-
IgG scanning, aseptic inflammation was considered present
(Fig. 3). Radionuclide uptake was characterized as absent
(2), faint (6), moderate (1), or marked (11).
Semiquantitative Analysis
Both 99mTc-MDP and 99mTc-IgG scans were further ana-
lyzed by drawing ellipsoid regions of interest over the sus-
pected abnormal and contralateral normal bony sites. The
entire lesion was included in the ellipsoid region, and mean
counts per pixel in each region were measured. The mean
uptake count ratios between abnormal and contralateral
normal sites were also obtained; the ratios were calculated
and considered to be indices, and the difference in indices
for osteomyelitis, cellulitis, and inflammation in the scans
were tested for significance.
FIGURE 1. Example images of osteomyelitis (arrows). Significant
uptake of 99mTc-MDP is seen in right first toe in all 3 phases of
skeletal scintigraphy, accompanied by intense radiotracer uptake
indicating osteomyelitis on 99mTc-IgG scan. (A) Flow phase of
99mTc-MDP skeletal scintigraphy. (B) Blood-pool phase of 99mTc-
MDP bone scintigraphy. (C) Delayed phase of 99mTc-MDP skeletal
scintigraphy. (D) Five-hour 99mTc-IgG scintigraphy. (E) Twenty-four-
hour 99mTc-IgG scintigraphy.
FIGURE 2. Example images of cellulitis (arrows). Significant
uptake of 99mTc-MDP is seen in left fifth metatarsi in flow and
blood-pool phases of skeletal scintigraphy, but activity is
normal in delayed phase and there is no significant uptake in
same region on 99mTc-IgG scan. (A) Flow phase of 99mTc-MDP
skeletal scintigraphy. (B) Blood-pool phase of 99mTc-MDP bone
scintigraphy. (C) Delayed phase of 99mTc-MDP skeletal scintigraphy.
(D) Five-hour 99mTc-IgG scintigraphy. (E) Twenty-four-hour 99mTc-
IgG scintigraphy.
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The clinicians determined the final diagnosis by consensus,
according to the MRI results, clinical presentation, wound
culture results, histopathologic results, and follow-up results.
Statistical Analysis
Sensitivity, specificity, negative and positive predictive
values, and accuracy were determined for each scan, and
the potential differences in osteomyelitis, cellulitis, and
aseptic inflammation on 99mTc-MDP scanning and on early
and late 99mTc-IgG scanning were analyzed using ANOVA.
A P value of less than 0.05 was considered significant.
Statistical analysis was performed using an IBM computer
and PASW software, version 18.0 (SPSS, Inc.).
RESULTS
The study included 3 women and 15 men (age range, 45–
80 y). From a total of 23 lesions, we observed 10 sites of
osteomyelitis, 10 sites of cellulitis, and 3 sites of aseptic
inflammation, of which 2 were caused by Charcot joint
(Table 1).
Both 99mTc-IgG and 99mTc-MDP scans showed excellent
sensitivity for the diagnosis of osteomyelitis, but specificity
was significantly compromised (69.2% and 53.8%, respec-
tively). 99mTc-IgG scanning could differentiate osteomyeli-
tis from cellulitis but not Charcot joint from osteomyelitis
(Table 2). Sensitivity, specificity, and accuracy in the diag-
nosis of osteomyelitis were, respectively, 100%, 53.8%, and
73.9% for 99mTc-MDP scanning; 100%, 69.2%, and 82.6%
for 5-h 99mTc-IgG scanning; and 60%, 76.9%, and 69.5%
for 24-h 99mTc-IgG scanning.
FIGURE 3. Example images of aseptic inflammation (arrows).
Significant uptake of 99mTc-MDP is seen in dorsal aspect of left
foot (talus bone) in all 3 phases of skeletal scintigraphy, but
there is no significant uptake on 99mTc-IgG scan. (A) Flow
phase of 99mTc-MDP skeletal scintigraphy. (B) Blood-pool
phase of 99mTc-MDP bone scintigraphy. (C) Delayed phase of
99mTc-MDP skeletal scintigraphy. (D) Five-hour 99mTc-IgG
scintigraphy. (E) Twenty-four-hour 99mTc-IgG scintigraphy.
TABLE 1
Scintigraphy Results
99mTc-IgG scan
Patient no. Ulcer location Radiograph 5-h 24-h
99mTc-MDP scan
(delayed phase) Definitive diagnosis
1 L calcaneus 2 11 11 11 OM
2 R first toe 2 6 6 1 Cellulitis
2 L talus 2 11 1 11 Aseptic inflammation
3 R fifth metatarsal 1 11 1 11 OM
4 R first toe 2 6 2 1 Cellulitis
4 L MTP joint 2 2 2 11 Aseptic inflammation
5 External malleolus 1 11 1 11 OM
6 L first toe 2 1 6 6 Cellulitis
7 R first toe 1 11 1 11 OM
7 R second toe 2 11 11 11 OM
8 R first toe 1 11 11 11 OM
9 L second metatarsal 2 11 11 11 OM
10 R second metatarsal 1 6 6 1 Cellulitis
11 R talus 2 11 11 11 Aseptic inflammation
12 L calcaneus 2 1 1 11 Cellulitis
13 R external malleolus 1 11 11 11 OM
14 Fifth metatarsals 2 6 6 1 Cellulitis
15 Surgical stump 2 11 11 11 Cellulitis
15 R fifth toe 2 11 11 11 Cellulitis
16 R third metatarsal 2 6 6 1 Cellulitis
17 R first toe 2 11 11 11 OM
18 Third metatarsals 1 11 1 11 OM
18 R first toe 2 6 6 6 Cellulitis
2 5 Absence of uptake; 6 5 faint uptake; 1 5 moderate uptake; 11 5 marked uptake; OM 5 osteomyelitis; MTP 5
metatarsophalyngeal.
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The osteomyelitis, cellulitis, and inflammation indices
are reported in Table 3. We did not find any significant
difference among the indices on 99mTc-MDP scintigraphy
or on 5 h-and 24-h 99mTc-IgG scintigraphy (P . 0.5).
DISCUSSION
We observed that both 99mTc-MDP and 99mTc-IgG scan-
ning can sensitively detect osteomyelitis; however, they
lack the appreciated specificity. Datz et al., investigating
53 patients with assumed infection, reported that the sensi-
tivity and specificity of 111In-IgG scanning was 97.9% and
94%, respectively. They found that this method can detect
chronic and acute osteomyelitis with equal sensitivity, and
simultaneous administration of antibiotics, steroids, and
antiinflammatory agents or concurrent diabetes and renal
dysfunction had no influence on scan sensitivity (6).
MRI can efficiently discriminate soft-tissue infection
from bone involvement and can effectively detect the
development of infection in anterior parts of the bone;
however, efficacy is dramatically compromised at the
midfoot and hindfoot (12–15). Despite high sensitivity,
the application of MRI for the recognition of osteomyelitis
in the diabetic foot is compromised by lower specificity
regarding Charcot neuropathic osteoarthropathy. In addi-
tion, if there is an inflammatory hyperemia, the diagnostic
accuracy is further decreased to 40%–50% (8).
Devillers et al., studying 56 diabetic foot ulcers in 40
patients, reported that the accuracy of radiography, 99mTc-
MDP scintigraphy, and 99mTc-exametazime–conjugated
leukocyte scintigraphy was 69.6%, 62.5%, and 92.9%,
respectively. They concluded that leukocyte-labeling
scintigraphy can be considered an outstanding tech-
nique for the identification of osteomyelitis in the diabetic
foot and can be useful in follow-up evaluation because
of an ability to predict osteomyelitis remission despite
the lack of complete clinical regression of the diabetic
ulcers (1). Although both sensitive and specific, leuko-
cyte labeling scintigraphy followed by bone marrow
scanning is also limited by inaccessibility, labor inten-
sity, and the risk of infectious blood handling (4).
Because of high sensitivity and the frequency of posi-
tive outcomes, the usefulness of labeled leukocyte
imaging as a screening test is uncertain; supplementa-
tion of skeletal imaging by labeled leukocyte imaging
has resulted in only marginal improvement of the test
(14). Skeletal scanning can sensitively be applied for
the determination of osteomyelitis but fails to differen-
tiate diabetic osteomyelitis from other osteoarthropathic
conditions because of higher bone turnover in both (16).
There have been extensive reports about the usefulness
of 99mTc-IgG scintigraphy in detecting a variety of
infections, including those of the chest, abdomen, hip,
and bone; however, as we also observed, this procedure
might not be able to discriminate infection from aseptic
inflammation (2,3,17,18). 111In-IgG scintigraphy differ-
entiated infectious from sterile inflammatory processes
in 25 adult patients with complicated osteomyelitis or
septic arthritis with a sensitivity of 90% and specificity
of 95% (19). Oyen et al. have reported that a recent bone
trauma or fracture might be misleading in IgG scan
interpretation (20–22). Unal et al., examining 20 cases
of diabetic foot, reported a 100% versus 94% sensitivity and
a 59% versus 100% specificity for 99mTc-IgG and 99mTc-
white blood cell labeling, respectively (18). Correspondingly,
we observed 4 cases of false-positive osteomyelitis, of which
2 were caused by cellulitis and 2 by aseptic infection, reflect-
ing a lack of specificity of 99mTc-IgG scintigraphy. In a
comprehensive study comparing 3 scanning techniques (tri-
TABLE 2
Accuracy of Various Scintigraphy Procedures in Osteomyelitis Diagnosis
Procedure
True-positive
(n)
False-positive
(n)
True-negative
(n)
False-negative
(n)
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
3-phase 99mTc-MDP 10 6 7 0 100 53.8 62.5 100
5-h 99mTc-IgG 10 4 9 0 100 69.2 71 100
24-h 99mTc-IgG 6 3 10 4 60 76.9 66.6 71.4
PPV 5 positive predictive value; NPV 5 negative predictive value.
TABLE 3
Osteomyelitis Indices in Various Scintigraphy Procedures
Procedure Osteomyelitis Cellulitis Aseptic inflammation
3-phase 99mTc-MDP 7.2 6 4.2 1.8 6 1.4 6.0 6 4.8
5-h 99mTc-IgG 5.1 6 1.8 2.3 6 1.0 4.4 6 1.5
24-h 99mTc-IgG 4.9 6 2.0 2.1 6 0.7 4.3 6 1.0
Data are mean 6 SD.
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phasic skeletal scintigraphy, 99mTc-white blood cell scin-
tigraphy, and 99mTc-IgG scintigraphy) in distinguishing
musculoskeletal infection from noninfectious inflammation
in 35 orthopedic patients, 2- to 6-h 99mTc-white blood cell
scintigraphy and 20- to 24-h 99mTc-IgG scintigraphy had the
greatest value (P, 0.01 and P, 0.016, respectively), with a
sensitivity of 96.6% and 96.5%, respectively, and a specific-
ity of 71% and 100%, respectively. The authors concluded
that 99mTc-IgG scintigraphy might be an alternative to
99mTc-white blood cell scintigraphy because of its simplicity
of preparation, similarity of accuracy, and safety, as well as
its being better able to show the spread of inflammation into
soft tissues (23).
We did not find any differences between the osteomye-
litis, cellulitis, and aseptic inflammation indices in 5-h and
24-h 99mTc-IgG scanning. Therefore, it seems there is no
need for delayed scintigraphy; one can evaluate the case
with only a single scan.
Our study had some shortcomings, the most important of
which were the relatively small sample size and the absence
of bone biopsy as a gold standard, which may influence the
results. However, we consider this problem to have been
reduced by the compound use of MRI, clinical presentation,
histopathologic examination, and follow-up evaluation.
Further well-designed studies would seem useful.
CONCLUSION
Both 99mTc-IgG and 99mTC-MDP scanning can be
applied to detect bone involvement in diabetic infection
with excellent sensitivity; however, their specificity is com-
promised, especially in distinguishing between infection
and inflammation. In addition, early 5-h images seem to
be adequate in 99mTc-IgG scintigraphy, and there is no need
for 24-h images.
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